Successful Completion of A$6.3B Institutional Placement
Filed with ASX · · 3 pages · English
completion of its A$6.3 billion (US$4.5 billion) institutional placement announced on Tuesday, 14 December 2021 (“Placement”). Proceeds raised under the Placement will contribute to funding CSL’s acquisition of Vifor Pharma Ltd. (“Vifor Pharma”). The Placement received strong support from existing shareholders and new investors. The Placement price was determined via a bookbuild process and ultima
Earlier from CSL
- Investor Presentation CSL Swiss Tender Acquisition of Vifor
- Swiss tender offer to acquire 100% of vifor pharma ltd
- Trading Halt
- CSL Statutory Accounts for the Full Year Ended 30 June 2021
- Update on CSL Agreement with uniQure
Later from CSL
- CSL completes A$750 million Share Purchase Plan
- Statutory Accounts for Half Year Ended 31 December 2021
- Update on Acquisition of Vifor Pharma
- CSL successfully issues bonds in US debt markets
- Vifor update ASX Announcement for lodgement
Follow CSL into a list and get an email when it puts out news.
Follow CSL